LYEL · Forms 3, 4, 5
Insider trades at Lyell Immunopharma, Inc.
1 insider sold $4K of Lyell Immunopharma, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Lyell Immunopharma, Inc. (LYEL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jarrad Mattieu Aguirre | Chief Medical Officer | Sell | 422 | $8.63 | $4K | Form 4 | |
| David Shook | Chief Medical Officer | Sell | 500 | $12.70 | $6K | Form 4 | |
| Jarrad Mattieu Aguirre | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Jarrad Mattieu Aguirre | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Lynn Seely | President and CEO | Sell | 9,589 | $15.54 | $149K | Form 4 | |
| Stephen J. Hill | Chief Operating Officer | Sell | 989 | $15.54 | $15K | Form 4 | |
| Gary K. Lee | Chief Scientific Officer | Sell | 1,457 | $15.54 | $23K | Form 4 | |
| Veronica Sanchez Bulis | VP, Corporate Controller | Sell | 621 | $14.34 | $9K | Form 4 | |
| Gary K. Lee | Chief Scientific Officer | Sell | 131 | $14.34 | $2K | Form 4 | |
| Stephen J. Hill | Chief Operating Officer | Sell | 89 | $14.34 | $1K | Form 4 | |
| Lynn Seely | President and CEO | Sell | 390 | $14.34 | $6K | Form 4 | |
| Innovative Cellular Therapeutics Holdings Ltd | 10% owner | Other | 44,000 | Form 4 | |||
| Innovative Cellular Therapeutics Holdings Ltd | 10% owner | Other | 38,500 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.